コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 n previously used in other ASD models (i.e., fragile X syndrome).
2 lated in autism spectrum disorder as well as fragile X syndrome.
3 nal regulation of a distinct set of genes in fragile X syndrome.
4 iology in 16p11.2 microdeletion syndrome and fragile X syndrome.
5 ysfunctional prefrontal cortex processing in fragile X syndrome.
6 l of the developmental neurological disorder Fragile X syndrome.
7 severative grooming states in a rat model of fragile X syndrome.
8 s primary contributors to the development of fragile X syndrome.
9 tions, including nociception, addiction, and fragile X syndrome.
10 of intellectual disability and autism called fragile X syndrome.
11 ies, including addiction, schizophrenia, and fragile X syndrome.
12 ressing neurons and in a Drosophila model of fragile X syndrome.
13 studies for the treatment of depression and fragile X syndrome.
14 ctrum disorder (ASD) associated with TSC and fragile X syndrome.
15 retardation 1 (Fmr1) knockout (KO) model of fragile X syndrome.
16 etogenesis and some developmental aspects of fragile X syndrome.
17 lts in silencing of the FMR1 gene and causes fragile X syndrome.
18 altered trajectory of synaptic maturation in fragile X syndrome.
19 g intergenerational transmissions leading to fragile X syndrome.
20 mily relationships with children affected by fragile X syndrome.
21 y regulates translation and which is lost in fragile X syndrome.
22 ribute to maladaptive auditory processing in fragile X syndrome.
23 y contribute to dendritic pathophysiology in Fragile X syndrome.
24 ty in neuropsychiatric conditions, including fragile X syndrome.
25 ntellectual disability are Down syndrome and Fragile X syndrome.
26 may underlie perceptual deficits related to fragile X syndrome.
27 RNA-binding protein whose deficiency causes fragile X syndrome.
28 fragile X mental retardation protein causes fragile X syndrome.
29 between FMRP and HTT in the pathogenesis of fragile X syndrome.
30 phase 2 clinical trials for the treatment of Fragile X Syndrome.
31 f many neurodevelopmental diseases including fragile X syndrome.
32 e and behavioural phenotypes associated with fragile X syndrome.
33 cific channelopathies in a mouse of model of Fragile X syndrome.
34 ated in autism spectrum disorders, including Fragile X syndrome.
35 brain disorders including schizophrenia and fragile X syndrome.
36 al and neuropsychiatric disorders, including fragile X syndrome.
37 omised in a severe monogenic form of autism, Fragile X Syndrome.
38 uit and likely represents a major feature of fragile X-syndrome.
39 region, and monogenic causes, as in Rett and fragile-X syndromes.
45 l system habituation to face and eye gaze in fragile X syndrome, a disorder characterized by eye-gaze
46 sally associated with the pathophysiology of fragile X syndrome, a leading inherited cause of intelle
47 This form of plasticity is deregulated in Fragile X Syndrome, a monogenic form of autism in humans
48 (FMRP) is well-studied, as its loss leads to fragile X syndrome, a neurodevelopmental disorder which
49 comprehensive manner, we begin by selecting fragile X syndrome, a neurogenetic disease with cognitiv
50 velopment in the cortex are key hallmarks of fragile X syndrome, a prevalent neurodevelopmental disor
51 cation and is the major causative factor for fragile X syndrome, a sex-linked disorder associated wit
53 or fly models of Alzheimer's disease and the Fragile X syndrome, allowing applications such as geneti
57 n this study, we focused on a mouse model of Fragile X syndrome and demonstrate how dendritic spines
58 lem in the Fmr1-knockout (KO) mouse model of Fragile X syndrome and describe potentially treatable un
59 DSCR1 is a novel regulator of FMRP and that Fragile X syndrome and Down syndrome may share disturban
60 ts with FMRP, a protein that is deficient in fragile X syndrome and is known to regulate the translat
62 g the pathogenic mechanisms of Hrp38-related Fragile X syndrome and PARP1-related retinal degeneratio
63 ter microstructure has been reported in both fragile X syndrome and psychiatric disorders, we looked
64 rcuit hyperexcitability are core features of fragile X syndrome and related autism spectrum disorder
66 hysiology of Autism Spectrum Disorder (ASD), Fragile X Syndrome and Tuberous Sclerosis, the role of o
67 BPN14770 may be useful for the treatment of fragile-X syndrome and other disorders with decreased cA
71 ced repetitive behaviors in a mouse model of Fragile X syndrome, and Arbaclofen improved some clinica
72 evelopmental disorders, Rett syndrome (RTT), fragile X syndrome, and CDKL5 syndrome, also affects fem
73 erapeutic approaches for spinal cord injury, Fragile X syndrome, and genetic learning deficits more g
75 s play a role in diseases, such as cancer or fragile X syndrome, and may also occur as a function of
76 enes involved in Tuberous Sclerosis Complex, Fragile X syndrome, Angelman syndrome and several synapt
78 in myotonic dystrophy, and (CGG)n repeats in fragile X syndrome, are also subject to double-strand br
79 pression) relevant to the pathophysiology of fragile X syndrome as well as neural correlates of cogni
80 neurodevelopment disorders such as Rett and fragile X syndromes, as well as complex behavioral disor
81 with a variety of neural diseases, including Fragile X syndrome, autism, and intellectual disability.
83 nterest as a drug target in the treatment of fragile X syndrome, autism, depression, anxiety, addicti
84 normal development and in disorders such as Fragile X syndrome, autism, epilepsy, addiction, anxiety
86 aggerated mGluR-dependent LTD is featured in fragile X syndrome, but the mechanisms that regulate mGl
88 tion patterns at specific genomic regions in fragile X syndrome cells, and identified dysregulated ge
89 al disorders, including Alzheimer's disease, fragile X syndrome, Down's syndrome, autism, epilepsy an
91 tterns of RNA-editing alterations in ASD and Fragile X syndrome, establishing this as a molecular lin
92 a comparison group of 25 individuals without fragile X syndrome (females, N=12) matched for general c
93 (ages 15-25 years) were 30 individuals with fragile X syndrome (females, N=14) and a comparison grou
97 ontrast the cognitive-behavioral features of fragile X syndrome (FraX) and Williams syndrome and to r
98 expansions, including those associated with fragile X syndrome, Friedreich's ataxia, and Huntington'
99 here that in mouse models PFC dysfunction in Fragile X Syndrome (FX) can be attributed to the continu
101 ptors (mGlu1/5) is a core pathophysiology of fragile X syndrome (FX); however, the differentially tra
102 ICANCE STATEMENT Sensory hypersensitivity in fragile X syndrome (FXS) and autism patients significant
105 is hypothesized to underlie the etiology of fragile X syndrome (FXS) and related autistic disorders.
106 oss and abnormal expression of FMRP occur in fragile X syndrome (FXS) and some forms of autism spectr
109 mark phenotypes reported in individuals with fragile X syndrome (FXS) are deficits in attentional fun
111 e behavioral and anatomical deficits seen in fragile X syndrome (FXS) are widely believed to result f
112 ategies.SIGNIFICANCE STATEMENT Patients with fragile X syndrome (FXS) exhibit signs of neuronal and c
113 ontributing to a "leak metabolism." In human Fragile X syndrome (FXS) fibroblasts and in Fmr1(-/y) mo
115 e X mental retardation protein (FMRP) causes fragile X syndrome (FXS) have largely focused on neurons
139 he inherited intellectual impairment disease fragile X syndrome (FXS) is neuronal hyperexcitability,
153 ssing deficits in FXS.SIGNIFICANCE STATEMENT Fragile X Syndrome (FXS) is the most common inheritable
162 specially in non-neuron glial cells, induces fragile X syndrome (FXS) phenotypes has just begun to be
167 tion 1 (Fmr1) knockout (KO) mice, a model of Fragile X Syndrome (FXS) with abrogated expression of th
168 ntagious itch behavior in the mouse model of fragile X syndrome (FXS), a common form of inherited int
171 le X mental retardation protein (FMRP) cause fragile X syndrome (FXS), a genetic disorder characteriz
173 ental retardation protein (FMRP) loss causes Fragile X syndrome (FXS), a major disorder characterized
175 autism spectrum disorders (ASDs), including fragile X syndrome (FXS), and frequently leads to tactil
176 f psychiatric diseases including depression, fragile X syndrome (FXS), anxiety, obsessive-compulsive
177 tructure and function is a major hallmark of fragile X syndrome (FXS), autism spectrum disorders (ASD
184 knock-out (ko) mice display key features of fragile X syndrome (FXS), including delayed dendritic sp
185 ty (ID) and autism spectrum disorders (ASD), Fragile X syndrome (FXS), is caused by loss of the mRNA-
186 trum disorder (ASD), including in those with fragile X syndrome (FXS), one of the most common genetic
188 othesize that this mechanism is defective in fragile X syndrome (FXS), the leading heritable cause of
190 ile X mental retardation 1 (FMR1) gene cause fragile X syndrome (FXS), the leading single-gene form o
192 Loss of the RNA binding protein FMRP causes Fragile X Syndrome (FXS), the most common cause of inher
196 X mental retardation protein (FMRP) leads to Fragile X syndrome (FXS), the most common form of inheri
197 get for diseases affecting synapses, such as fragile X syndrome (FXS), the most common heritable auti
200 mental retardation protein (FMRP) linked to fragile X syndrome (FXS), the most common heritable ment
201 llectual disability and other afflictions of fragile X syndrome (FXS), the most common inherited caus
202 e X mental retardation protein (FMRP) causes fragile X syndrome (FXS), the most common inherited inte
204 n-enriched RNA-BP, whose deficiency leads to Fragile X Syndrome (FXS), the most prevalent inherited i
205 primary somatosensory cortex (S1) neurons in Fragile X syndrome (FXS), which is a common inherited ca
207 lts in a spectrum of cognitive deficits, the fragile X syndrome (FXS), while aging individuals with d
209 e X mental retardation protein (FMRP) causes fragile X syndrome (FXS), yet the mechanisms underlying
210 ility is one of the major characteristics of fragile X syndrome (FXS), yet the molecular mechanisms o
230 th distinct molecular pathologies, including fragile X syndrome (FXS; full mutation range, greater th
232 nce for differences in PPI in a rat model of Fragile-X Syndrome (FXS) compared with wild-type control
235 ation (and significant sensitization) in the fragile X syndrome group was found in the cingulate gyru
237 that occurs in a mouse model (Fmr1(-/-)) of fragile X syndrome, group I mGluR-activated translation
238 gh incidence of autistic behaviours, such as fragile X syndrome, has the potential to identify genes
241 entiated to dorsal forebrain cell fates, our fragile X syndrome human pluripotent stem cell lines exh
243 expansions in diseases such as hemophilia A, fragile X syndrome, Hunter syndrome, and Friedreich's at
244 omeres, and trinucleotide repeats (linked to fragile X syndrome, Huntington disease, etc.), account f
245 ntal Retardation Protein, which is absent in Fragile X syndrome, in adult CA1 and L5 PFC neurons regu
246 isturbed in the Fmr1 knock-out (KO) model of fragile X syndrome, in which stabilization of both actin
247 nd circuit hyperexcitability associated with Fragile X syndrome, including patients with complete del
255 This finding is of high relevance because Fragile X syndrome is the most common monogenetic cause
257 ause amyotrophic lateral sclerosis (ALS) and fragile X syndrome, is challenging for short-read whole-
258 esis has been implicated in the pathology of fragile X syndrome, it remains unknown whether group I m
259 man's syndrome (34%), CHARGE syndrome (30%), fragile X syndrome (male individuals only 30%; mixed sex
260 ndicating that therapeutic interventions for fragile X syndrome may benefit patients with SYNGAP1 hap
262 zation therapy, which may help patients with fragile X syndrome modulate anxiety and arousal associat
263 to mGluR5 dysfunction and phenotypes in the fragile X syndrome mouse model, Fmr1 knockout (Fmr1(-/y)
264 tion has been most well characterized in the fragile X syndrome mouse model, the Fmr1 knock-out (KO)
266 e revealed maladaptive auditory responses in fragile X syndrome patients and Fmr1 KO mice, suggesting
267 revious white matter differences reported in fragile X syndrome patients, suggesting common pathogeni
274 of disorders where it is disrupted, such as Fragile X syndrome, Rett syndrome, epilepsy, major depre
275 ith neurological diseases, including FMRP in fragile X syndrome; TDP-43, FUS (fused in sarcoma), angi
276 ulated gene- and network-level correlates of fragile X syndrome that are associated with developmenta
277 We then describe what we have learned from fragile X syndrome that may be applicable to other psych
286 ity has been implicated in neuropathology of fragile X syndrome, the most common inheritable cause of
288 phosphorylation in Fmr1 KO mice, a model of fragile X syndrome, the most common monogenetic cause of
290 ucleotide repeats, which are associated with fragile X syndrome, the most widespread inherited cause
291 rinucleotide repeats has been shown to cause fragile-X syndrome, the most widespread inherited cause
292 s known about their functional properties in Fragile X syndrome: the most common form of inherited co
293 he impairment in spinogenesis, a hallmark in Fragile X syndrome, thereby linking the regulation of ac
294 elopmental and psychiatric disorders such as fragile X syndrome, this work uncovers a unique translat
295 rtex of Fmr1 knock-out (KO) mice, a model of Fragile-X Syndrome, to test the E/I imbalance theory.
296 identified as a phenotypic feature common to fragile X syndrome, tuberous sclerosis complex 1 and 2,
297 2 (both linked to FMR1, which is involved in fragile X syndrome), VIP (involved in social-cognitive d
299 oid signalosome as a molecular substrate for fragile X syndrome, which might be targeted by therapy.
300 onic dystrophy, spinal muscular atrophy, and fragile X syndrome, with broader implications for other